OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 131 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,540,000 | -55.1% | 917,303 | -29.0% | 0.28% | -48.0% |
| Q1 2015 | $10,121,000 | +61.0% | 1,292,684 | +24.6% | 0.54% | +65.5% |
| Q4 2014 | $6,285,000 | -13.2% | 1,037,188 | -39.0% | 0.32% | -11.9% |
| Q3 2014 | $7,243,000 | -33.1% | 1,700,371 | -3.0% | 0.37% | -26.3% |
| Q2 2014 | $10,832,000 | +94.9% | 1,752,792 | +105.0% | 0.50% | +107.0% |
| Q1 2014 | $5,557,000 | – | 855,004 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |